Maritess Esguerra | Principal Pharmacovigilance Process Leader
Genentech

Maritess Esguerra, Principal Pharmacovigilance Process Leader, Genentech

Appearances:



World Drug Safety Congress USA 2019 - Day 2 @ 13:40

3) Reference safety information: RSI used in Clinical Trials based on the CTFG RSI Q&A Document and the EFPIA Draft Paper in response to such document

last published: 17/Apr/19 11:55 GMT

back to speakers

Get Involved At World Drug Safety Congress Americas

 

To Sponsor Or Exhibit


Joseph Sica
joseph.sica@terrapinn.com
t/ +1 646 619 1839

 

 

 

To Speak


Michaela Deitrick
michaela.deitrick@terrapinn.com
t/ +1 646 619 1799

 

 

 

To Register


Joe McManus
joseph.mcmanus@terrapinn.com
t/ +1 646 619 1774